The association of ferritin with subclinical coronary artery calcification is an expression of underlying cardiometabolic risk
S Gensluckner(Paracelsus Medical University), Elmar Aigner, Bernhard Paulweber(Paracelsus Medical University), Mathias Ausserwinkler(Paracelsus Medical University), Bernhard Wernly(Paracelsus Medical University), J.L. Eberhardt(Universitätskliniken Salzburg), Florian Koutny(Universitätsklinikum St. Pölten), Vanessa Frey(Paracelsus Medical University), Christian Datz(Paracelsus Medical University), Stephan Zandanell(Universitätskliniken Salzburg), Eugen Trinka(Paracelsus Medical University), Patrick B. Langthaler(Paracelsus Medical University), Bernhard Iglseder(Paracelsus Medical University)
Cited by 0
Related Papers
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
|The Lancet|2017|843
Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function
|Nature Communications|2016|535
Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel
|Archives of Medical Science|2017|288
Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel
|Nutrition Reviews|2017|286